Verition Fund Management LLC Supernus Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$27.11 - $35.17 $311,602 - $404,243	11,494 New	11,494 $392,000
Q3 2023 Nov 14, 2023	BUY	$27.57 - $32.91 $270,323 - $322,682	9,805 New	9,805 $270,000
Q1 2020 May 15, 2020	SELL	$14.45 - $24.69 $627,130 - $1.07 Million	-43,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.93 - $29.13 $864,962 - $1.26 Million	43,400 New	43,400 $1.03 Million
Q3 2019 Nov 14, 2019	SELL	$25.47 - $33.37 $914,322 - $1.2 Million	-35,898 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$29.96 - $38.87 $1.08 Million - $1.4 Million	35,898 New	35,898 $1.19 Million

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.97B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.